Anlon Healthcare Ltd vs Stallion India Fluorochemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 114.35 as of 24 Mar 12:12 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Stallion India Fluorochemicals Ltd changed from 16.6 on March 2025 to 16.6 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Stallion India Fluorochemicals Ltd changed from ₹ 537.11 crore on March 2025 to ₹ 537.11 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Stallion India Fluorochemicals Ltd for the Dec '25 is ₹ 104.88 crore as compare to the Sep '25 revenue of ₹ 105.76 crore. This represent the decline of -0.83% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Stallion India Fluorochemicals Ltd for the Dec '25 is ₹ 13.56 crore as compare to the Sep '25 ebitda of ₹ 15.77 crore. This represent the decline of -14.01% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Stallion India Fluorochemicals Ltd changed from ₹ 8.42 crore to ₹ 11.13 crore over 7 quarters. This represents a CAGR of 17.29% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Stallion India Fluorochemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Limited was incorporated as Private Limited Company as 'Stallion India Fluorochemicals Private Limited' in Mumbai on September 5, 2002, with the RoC. The status of the Company got converted to Public Limited and name of the Company was changed to Stallion India Fluorochemicals Limited through a fresh Certificate of Incorporation dated October 5, 2023 issued by the RoC. The Company issued 2,21,61,396 equity shares of face value of Rs 10 each, by raising Rs 199.45 crores, consisting a fresh issue of 1,78,58,740 equity shares aggregating to Rs 160.72 crores and the offer for sale of 43,02,656 equity shares aggregating to Rs 38.72 crores in January, 2025 Stallion India Fluorochemicals Limited, commonly known as Stallion, is a Mumbai-based company founded by Shazad Sheriar Rustomji.

FAQs for the comparison of Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Stallion India Fluorochemicals Ltd?

Market cap of Anlon Healthcare Ltd is 608 Cr while Market cap of Stallion India Fluorochemicals Ltd is 1,266 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd?

The stock performance of Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd?

As of March 24, 2026, the Anlon Healthcare Ltd stock price is INR ₹114.45. On the other hand, Stallion India Fluorochemicals Ltd stock price is INR ₹109.1.

How do dividend payouts of Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Stallion India Fluorochemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.